Anaplastic thyroid cancer
- PMID: 26313900
- DOI: 10.1097/MED.0000000000000189
Anaplastic thyroid cancer
Abstract
Purpose of review: Anaplastic thyroid cancer (ATC) is a rare malignancy of the thyroid with a high mortality rate. Conventional therapy has not been effective. Several biological agents are being investigated. The purpose of the review is to highlight the current standards for treatment and review new targets for treating ATC.
Recent findings: Retrospective studies have led to formulation of guidelines for management, including those by the American Thyroid Association. An expansion in the understanding of the genetic mutations has led to several newer biological agents being tested to treat ATC. Aurora kinase inhibitors, PPAR γ agonists, and vascular targeting agents are some of the latest therapeutic agents that have shown promise and could become standard of therapy with further supporting research.
Summary: Further well coordinated preclinical and clinical research is needed to support the emerging treatments for ATC.
Similar articles
-
Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.J Nippon Med Sch. 2018;85(1):18-27. doi: 10.1272/jnms.2018_85-3. J Nippon Med Sch. 2018. PMID: 29540641 Review.
-
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.J Clin Endocrinol Metab. 2015 Jan;100(1):35-42. doi: 10.1210/jc.2014-2803. J Clin Endocrinol Metab. 2015. PMID: 25347569 Free PMC article. Review.
-
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Nat Rev Endocrinol. 2017 Nov;13(11):644-660. doi: 10.1038/nrendo.2017.76. Epub 2017 Jul 14. Nat Rev Endocrinol. 2017. PMID: 28707679 Review.
-
Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.Thyroid. 2017 May;27(5):672-681. doi: 10.1089/thy.2016.0395. Epub 2017 Feb 16. Thyroid. 2017. PMID: 28068873 Free PMC article.
-
Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.Endocr Relat Cancer. 2015 Jun;22(3):319-29. doi: 10.1530/ERC-14-0510. Endocr Relat Cancer. 2015. PMID: 25972243
Cited by
-
Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.Cancer Biol Ther. 2018 Jun 3;19(6):484-496. doi: 10.1080/15384047.2018.1433502. Epub 2018 Mar 26. Cancer Biol Ther. 2018. PMID: 29504819 Free PMC article.
-
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26. Cell Rep. 2024. PMID: 38412093 Free PMC article.
-
Case Reports: A role of postoperative radiation therapy in completely resected early stage intrathyroid thymic carcinoma: a case report and literature review of the diagnosis and treatment.Front Oncol. 2023 Oct 2;13:1234961. doi: 10.3389/fonc.2023.1234961. eCollection 2023. Front Oncol. 2023. PMID: 37849817 Free PMC article.
-
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.Front Oncol. 2021 Apr 12;11:569429. doi: 10.3389/fonc.2021.569429. eCollection 2021. Front Oncol. 2021. PMID: 33912440 Free PMC article.
-
Development of a novel dynamic nomogram for predicting overall survival in anaplastic thyroid cancer patients with distant metastasis: a population-based study based on the SEER database.Front Endocrinol (Lausanne). 2024 Jul 4;15:1375176. doi: 10.3389/fendo.2024.1375176. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39027479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials